BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

559 related articles for article (PubMed ID: 18068482)

  • 1. Pleiotropic effects of statin therapy: molecular mechanisms and clinical results.
    Wang CY; Liu PY; Liao JK
    Trends Mol Med; 2008 Jan; 14(1):37-44. PubMed ID: 18068482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statins and cardiovascular diseases: from cholesterol lowering to pleiotropy.
    Zhou Q; Liao JK
    Curr Pharm Des; 2009; 15(5):467-78. PubMed ID: 19199975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pleiotropic effects of statins. - Basic research and clinical perspectives -.
    Zhou Q; Liao JK
    Circ J; 2010 May; 74(5):818-26. PubMed ID: 20424337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical implications for statin pleiotropy.
    Liao JK
    Curr Opin Lipidol; 2005 Dec; 16(6):624-9. PubMed ID: 16276239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulatory effects of HMG-CoA reductase inhibitors in diabetic microangiopathy.
    Danesh FR; Kanwar YS
    FASEB J; 2004 May; 18(7):805-15. PubMed ID: 15117885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of statins on 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition beyond low-density lipoprotein cholesterol.
    Liao JK
    Am J Cardiol; 2005 Sep; 96(5A):24F-33F. PubMed ID: 16126020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pleiotropic effects of statins.
    Liao JK; Laufs U
    Annu Rev Pharmacol Toxicol; 2005; 45():89-118. PubMed ID: 15822172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial dysfunction, oxidative stress and inflammation in atherosclerosis: beneficial effects of statins.
    Lahera V; Goicoechea M; de Vinuesa SG; Miana M; de las Heras N; Cachofeiro V; Luño J
    Curr Med Chem; 2007; 14(2):243-8. PubMed ID: 17266583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pleiotropic Benefits of Statins in Cardiovascular Diseases.
    Wasim R; Ansari TM; Ahsan F; Siddiqui MH; Singh A; Shariq M; Parveen S
    Drug Res (Stuttg); 2022 Nov; 72(9):477-486. PubMed ID: 35868336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors.
    Takemoto M; Liao JK
    Arterioscler Thromb Vasc Biol; 2001 Nov; 21(11):1712-9. PubMed ID: 11701455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholesterol-independent effects of statins in inflammation, immunomodulation and atherosclerosis.
    Arnaud C; Veillard NR; Mach F
    Curr Drug Targets Cardiovasc Haematol Disord; 2005 Apr; 5(2):127-34. PubMed ID: 15853754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging views of statin pleiotropy and cholesterol lowering.
    Yu D; Liao JK
    Cardiovasc Res; 2022 Jan; 118(2):413-423. PubMed ID: 33533892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pleiotropic effects of statins and related pharmacological experimental approaches.
    Alegret M; Silvestre JS
    Methods Find Exp Clin Pharmacol; 2006 Nov; 28(9):627-56. PubMed ID: 17200729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rho GTPases, statins, and nitric oxide.
    Rikitake Y; Liao JK
    Circ Res; 2005 Dec; 97(12):1232-5. PubMed ID: 16339495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunomodulatory effects of HMG-CoA reductase inhibitors.
    Danesh FR; Anel RL; Zeng L; Lomasney J; Sahai A; Kanwar YS
    Arch Immunol Ther Exp (Warsz); 2003; 51(3):139-48. PubMed ID: 12894868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering.
    Pedersen TR
    Am J Cardiovasc Drugs; 2010; 10 Suppl 1():10-7. PubMed ID: 21391729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does it matter whether or not a lipid-lowering agent inhibits Rho kinase?
    Liao JK
    Curr Atheroscler Rep; 2007 Nov; 9(5):384-8. PubMed ID: 18001621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pleiotropic Effects of Statins on the Cardiovascular System.
    Oesterle A; Laufs U; Liao JK
    Circ Res; 2017 Jan; 120(1):229-243. PubMed ID: 28057795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct vascular effects of HMG-CoA reductase inhibitors.
    Laufs U; Liao JK
    Trends Cardiovasc Med; 2000 May; 10(4):143-8. PubMed ID: 11239793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rho/Rho-associated coiled-coil forming kinase pathway as therapeutic targets for statins in atherosclerosis.
    Sawada N; Liao JK
    Antioxid Redox Signal; 2014 Mar; 20(8):1251-67. PubMed ID: 23919640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.